These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10534133)

  • 1. Age-distribution, risk factors and mortality in smokers and non-smokers with acute myocardial infarction: a review. TRACE study group. Danish Trandolapril Cardiac Evaluation.
    Ottesen MM; Jørgensen S; Kjøller E; Videbaek J; Køber L; Torp-Pedersen C
    J Cardiovasc Risk; 1999 Oct; 6(5):307-9. PubMed ID: 10534133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey).
    Gottlieb S; Boyko V; Zahger D; Balkin J; Hod H; Pelled B; Stern S; Behar S
    J Am Coll Cardiol; 1996 Nov; 28(6):1506-13. PubMed ID: 8917265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic importance of smoking status at the time of acute myocardial infarction in 6676 patients. TRACE Study Group.
    Jørgensen ; Køber L; Ottesen MM; Torp-Pedersen C; Videbaek J; Kjøller E
    J Cardiovasc Risk; 1999 Feb; 6(1):23-7. PubMed ID: 10197289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis.
    Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Kurisu S; Sakai K; Ueda K
    Am Heart J; 1997 Nov; 134(5 Pt 1):955-60. PubMed ID: 9398109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study.
    Andrikopoulos GK; Richter DJ; Dilaveris PE; Pipilis A; Zaharoulis A; Gialafos JE; Toutouzas PK; Chimonas ET
    Eur Heart J; 2001 May; 22(9):776-84. PubMed ID: 11350110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.
    Mueller HS; Cohen LS; Braunwald E; Forman S; Feit F; Ross A; Schweiger M; Cabin H; Davison R; Miller D
    Circulation; 1992 Apr; 85(4):1254-64. PubMed ID: 1555269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2).
    Gourlay SG; Rundle AC; Barron HV
    Nicotine Tob Res; 2002 Feb; 4(1):101-7. PubMed ID: 11906686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis.
    Purcell IF; Newall N; Farrer M
    QJM; 1999 Jun; 92(6):327-33. PubMed ID: 10616708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and first acute myocardial infarction: age, mortality and smoking cessation rate.
    Weiner P; Waizman J; Weiner M; Rabner M; Magadle R; Zamir D
    Isr Med Assoc J; 2000 Jun; 2(6):446-9. PubMed ID: 10897236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Revision of the "Smoker's Paradox": smoking is not a good prognostic factor immediately after myocardial infarction].
    Himbert D; Juliard JM; Golmard JL; Feldman LJ; Aubry P; Benamer H; Karila-Cohen D; Gauci L; Steg PG
    Arch Mal Coeur Vaiss; 2001 Apr; 94(4):262-8. PubMed ID: 11387931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between smoking and long-term outcomes after non-ST-segment elevation myocardial infarction in older patients.
    Shen L; Peterson ED; Li S; Thomas L; Alexander K; Xian Y; Wang TY; Roe MT; He B; Shah BR
    Am Heart J; 2013 Dec; 166(6):1056-62. PubMed ID: 24268221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Circulation; 1993 Jan; 87(1):53-8. PubMed ID: 8419024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
    Barbash GI; Reiner J; White HD; Wilcox RG; Armstrong PW; Sadowski Z; Morris D; Aylward P; Woodlief LH; Topol EJ
    J Am Coll Cardiol; 1995 Nov; 26(5):1222-9. PubMed ID: 7594035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking and myocardial infarction case-fatality: hospital and population approach.
    Elosua R; Vega G; Rohlfs I; Aldasoro E; Navarro C; Cabades A; Demissie S; Segura A; Fiol M; Moreno-Iribas C; Echanove I; Tormo MJ; Arteagoitia JM; Sala J; Marrugat J;
    Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):561-7. PubMed ID: 17667648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction.
    Grines CL; Topol EJ; O'Neill WW; George BS; Kereiakes D; Phillips HR; Leimberger JD; Woodlief LH; Califf RM
    Circulation; 1995 Jan; 91(2):298-303. PubMed ID: 7805231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis.
    de Chillou C; Riff P; Sadoul N; Ethevenot G; Feldmann L; Isaaz K; Simon JP; Boursier M; Khalifé K; Thisse JY; Aliot E
    J Am Coll Cardiol; 1996 Jun; 27(7):1662-8. PubMed ID: 8636551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cessation of smoking after myocardial infarction.
    Wilhelmsen L
    J Cardiovasc Risk; 1998 Jun; 5(3):173-6. PubMed ID: 10201554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).
    Tan NS; Goodman SG; Cantor WJ; Tan MK; Yan RT; Bagnall AJ; Mehta SR; Fitchett D; Strauss BH; Yan AT;
    Am J Cardiol; 2014 Oct; 114(7):955-61. PubMed ID: 25118119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking is not a protective factor for patients with acute myocardial infarction: the viewpoint of the GISSI-2 Study.
    Maggioni AP; Piantadosi F; Tognoni G; Santoro E; Franzosi MG
    G Ital Cardiol; 1998 Sep; 28(9):970-8. PubMed ID: 9788035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower age at first myocardial infarction in female compared to male smokers.
    Bähler C; Gutzwiller F; Erne P; Radovanovic D
    Eur J Prev Cardiol; 2012 Oct; 19(5):1184-93. PubMed ID: 21930718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.